Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy

Completed

Conditions studied: Acute Myeloid Leukemia

In brief

This is a prospective, observational study to collect stool and blood from acute myeloid leukemia patients undergoing intensive chemotherapy.

Key facts

Study ID

NCT03728699

Run by

Masonic Cancer Center, University of Minnesota

People needed

54

Starts

2018-01-02

Expected to finish

2022-02-18

Last updated by the study team

2023-11-03

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (ages 18 - 99 years) undergoing inpatient intensive chemotherapy for newly diagnosed, refractory, or relapsed AML. Patients may or may not have been exposed to any type of therapy before.
• Any intensive chemotherapy regimen defined as a planned \~4 week inpatient stay. Chemotherapy may be delivered for any number of days and on any schedule. Patients may be discharged from the hospital sooner than 4 weeks if the treating physician choose so, but the expectation at the initiation of chemotherapy must be \~4 weeks of inpatient stay, as is typical.
• Able to provide written voluntary consent before performance of any study related procedure.

Where it is running

• Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.